$Forte Biosciences (FBRX.US)$On my top watchlist. News/update on their R&D on 3rd December 2024, Phase 1 top-line result by the second quarter of 2025. They have cash available which will sustain the company operations for 12 months (exclude the recent oversubscribed private placement 53mil)
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Forte Biosciences Stock Forum
Forte's Celiac Treatment Shows Promise: Zero Dropouts and $58.4M War Chest
News/update on their R&D on 3rd December 2024, Phase 1 top-line result by the second quarter of 2025. They have cash available which will sustain the company operations for 12 months (exclude the recent oversubscribed private placement 53mil)
No comment yet